Children age five to 11 who are moderately to severely immunocompromised should get a third dose of COVID-19 vaccine, the National Advisory Committee on Immunization (NACI) recommended on Friday.
Last September, NACI recommended that people 12 years of age and over who are moderately to severely immunocompromised should receive three doses of the vaccine.
The dose given to children and adolescents should be the Pfizer-BioNTech mRNA vaccine, the committee said.
According to the NACI guidance published on Friday, children and teens are considered immunocompromised if they have one of the following conditions:
- Active treatment for solid tumour or hematologic malignancies
- Receipt of solid-organ transplant and taking immunosuppressive therapy
- Receipt of chimeric antigen receptor (CAR)-T-cell therapy or stem cell transplant (within two years of transplantation or taking immunosuppression therapy)
- Moderate to severe primary immunodeficiency with associated humoral and/or cell-mediated immunodeficiency or immune dysregulation
- Treatment of HIV with immunosuppressive therapies.